Schedule 13G ownership disclosure
DBV TECHNOLOGIES SA
Ordinary Shares, EURO0.10 nominal value per share, represented by American Depository Shares · CUSIP: 23306J309
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Venrock Healthcare Capital Partners II, L.P.
Shares: 14,286,553.00 · Class: 9.8%
- VHCP Co-Investment Holdings II, LLC
Shares: 14,286,553.00 · Class: 9.8%
- VHCP Management II, LLC
Shares: 14,286,553.00 · Class: 9.8%
- Venrock Healthcare Capital Partners III, L.P.
Shares: 14,286,553.00 · Class: 9.8%
- VHCP Co-Investment Holdings III, LLC
Shares: 14,286,553.00 · Class: 9.8%
- Venrock Healthcare Capital Partners EG, L.P.
Shares: 14,286,553.00 · Class: 9.8%
- VHCP Management III, LLC
Shares: 14,286,553.00 · Class: 9.8%
- VHCP Management EG, LLC
Shares: 14,286,553.00 · Class: 9.8%
- Nimish Shah
Shares: 14,286,553.00 · Class: 9.8%
- Bong Y. Koh
Shares: 14,286,553.00 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-022017
- Form type
- SCHEDULE 13G/A
- Filer
- DBV Technologies S.A.
- CIK
- CIK 1613780
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership